Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Timber Pharmaceuticals, Inc. | Director | Common Stock, par value $0.001 per share | 6.1K | $9.94K | $1.63 | Apr 15, 2023 | Direct |
Timber Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 4.1K | Apr 15, 2023 | Direct | ||
Kadmon Holdings, Inc. | Director | Stock Option (right to buy) | 0 | $5.54 | Nov 9, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TMBR | Timber Pharmaceuticals, Inc. | Apr 15, 2023 | 2 | $0 | 4 | Apr 18, 2023 | Director |
TMBR | Timber Pharmaceuticals, Inc. | Apr 15, 2022 | 2 | $0 | 4 | Apr 19, 2022 | Director |
KDMN | Kadmon Holdings, Inc. | Nov 9, 2021 | 4 | -$2.19M | 4 | Nov 9, 2021 | Director |
TMBR | Timber Pharmaceuticals, Inc. | Jul 1, 2021 | 1 | $0 | 4 | Jul 6, 2021 | Director |
KDMN | Kadmon Holdings, Inc. | May 12, 2021 | 1 | $0 | 4 | May 13, 2021 | Director |